BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fujita M, Matsumoto H, Inafuku Y, Toyama J, Fujita J. A retrospective observational study of the treatment of a nosocomial infection caused by oseltamivir-resistant influenza virus A with baloxavir marboxil. Respir Investig 2020;58:403-8. [PMID: 32605828 DOI: 10.1016/j.resinv.2020.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fujita J. Clinical application of baloxavir marboxil in the treatment of influenza. Respir Investig 2020;58:301-4. [PMID: 32669226 DOI: 10.1016/j.resinv.2020.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kuo YC, Lai CC, Wang YH, Chen CH, Wang CY. Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials. J Microbiol Immunol Infect 2021:S1684-1182(21)00092-X. [PMID: 34020891 DOI: 10.1016/j.jmii.2021.04.002] [Reference Citation Analysis]
3 Palomba E, Castelli V, Renisi G, Bandera A, Lombardi A, Gori A. Antiviral Treatments for Influenza. Semin Respir Crit Care Med 2021;42:859-72. [PMID: 34918326 DOI: 10.1055/s-0041-1733830] [Reference Citation Analysis]